The rapid expansion of gene therapy, mRNA therapeutics, synthetic biology, and cell engineering is continuously driving the demand for high-quality plasmid DNA production and analysis.
By 2026–2027, the global plasmid DNA manufacturing market is expected to maintain strong double-digit growth, fueled by the rapid commercialization of gene and cell therapies, viral vector manufacturing, DNA vaccines, and synthetic biology applications. Meanwhile, the AAV gene therapy market continues to expand at a CAGR exceeding 18%, with increasing requirements for scalable plasmid preparation, quality control, and sequencing validation workflows.
Behind every successful gene editing experiment, viral vector production process, or synthetic biology platform lies one essential foundation: massive numbers of plasmids and PCR products.
However, many laboratories are still trapped in a “manual high-throughput” workflow.
Many labs are stuck with slow, manual plasmid workflows. Essential steps like purification, cloning, and extraction consume hours of repetitive labor, often taking an entire afternoon for just one 96-well plate. This not only slows down research but also increases the risk of human error and inconsistent results. As demand grows, labs urgently need standardized, automated solutions to save time and ensure accuracy.
|
Traditional Workflow Challenges |
Impact |
|
Repetitive pipetting and centrifugation |
Heavy hands-on workload |
|
Large-scale DNA quantification |
Low throughput |
|
Manual normalization and recording |
Increased human error |
|
Multiple purification and cloning steps |
Long turnaround time |
|
High-throughput sequencing preparation |
Difficult standardization |
Yeasen Integrated Plasmid Workflow Solution
To address these challenges, Yeasen provides a comprehensive plasmid workflow solution covering plasmid synthesis to sequencing validation. This integrated solution helps laboratories simplify operations, improve reproducibility, and accelerate plasmid-related research and manufacturing workflows.
Enzymatic Plasmid Synthesis: Building Circular DNA Efficiently
Traditional plasmid construction methods often rely on multi-step ligation and transformation workflows. In contrast, enzymatic DNA synthesis and assembly technologies are enabling more flexible and scalable plasmid generation strategies.
Yeasen provides key enzyme components for plasmid enzymatic synthesis workflows, including TelN Protelomerase(Cat#14540), Phi29 DNA Polymerase, and various exonucleases, alongside high-quality dNTPs and primers. Ideal for circular DNA synthesis, isothermal amplification, and synthetic biology, these enzymes enable high-fidelity, cell-free DNA engineering. By adopting Yeasen’s enzymatic solutions, labs can achieve scalable, automation-friendly workflows with reduced hands-on time, lower error rates, and greater design flexibility compared to conventional cloning.
Figure 1. TelN cleavage activity analysis. (M: Marker; C: Supercoiled plasmid control）
Automated High-Throughput Plasmid Extraction
Optimized for automated 96-well workflows, Yeasen’s magnetic bead-based plasmid extraction kits(Cat#18549) ensure high yield, excellent integrity, and low endotoxin levels. Combined with the AP-96N Automated Nucleic Acid Extractor(Cat#80510), the workflow minimizes manual labor. Tests using the 18549ES kit and 80510ES platform on bacterial cultures (5–20 mL) confirmed stable recovery and high-quality plasmid extraction across all sample volumes.
|
No. |
Extraction Method |
Sample (Culture Vol.) |
Concentration (ng/μL) |
260/280 |
260/230 |
Elution Vol. (μL) |
Total Yield (μg) |
|
1 |
Yeasen |
10 mL |
667.41 |
1.88 |
2.40 |
35 |
23.35 |
|
2 |
10 mL |
762.23 |
1.89 |
2.36 |
35 |
26.67 |
|
|
3 |
15 mL |
1253.10 |
1.91 |
2.45 |
35 |
43.85 |
|
|
4 |
15 mL |
1258.95 |
1.89 |
2.44 |
35 |
44.06 |
|
|
5 |
20 mL |
569.86 |
1.82 |
2.10 |
45 |
25.64 |
|
|
6 |
20 mL |
680.38 |
1.84 |
2.23 |
45 |
30.61 |
|
|
7 |
Supplier T* |
10 mL |
425.09 |
1.86 |
2.20 |
35 |
14.87 |
|
8 |
10 mL |
437.83 |
1.86 |
0.49 |
35 |
15.32 |
|
|
9 |
15 mL |
592.78 |
1.90 |
1.88 |
35 |
20.74 |
|
|
10 |
15 mL |
503.47 |
1.88 |
2.25 |
35 |
17.60 |
|
|
11 |
20 mL |
288.72 |
1.94 |
2.32 |
45 |
13.00 |
|
|
12 |
20 mL |
404.71 |
1.88 |
2.37 |
45 |
18.21 |
Residual Plasmid DNA Detection for Biopharmaceutical Quality Control
For gene therapy, cell therapy, and mRNA manufacturing, residual plasmid DNA detection is essential. Yeasen’s Plasmid DNA Residue Detection Kit(Cat#41323) offers high sensitivity and reproducible, consistent results across platforms, with validation proving stable performance on diverse qPCR instruments and sample types.
The kit has a linear range of 4×10¹ copies/μL to 4×10⁶ copies/μL, with an R² value of 1, amplification efficiency between 90% and 110%, and a coefficient of variation (CV) of <15% for detected values at each concentration.
Figure 2. Plasmid DNA Standard Curve Linearity Plot (Left) and Amplification Curve Linear Profile (Right)
|
Brand |
Model |
Amplification Efficiency |
R² |
LOQ Conc. (copies/μL) |
CV |
|
Thermo |
ABI 7500 |
98.13% |
1 |
4 |
15.33% |
|
Thermo |
ABI Quant Studio 5 |
97.86% |
1 |
4 |
18.54% |
|
Shanghai Hongshi |
SLAN-96S |
101.90% |
0.999 |
4 |
18.66% |
Full-Length Plasmid Sequencing Solutions
As plasmid complexity increases, full-length sequencing is becoming essential for sequence verification and structural integrity analysis.Yeasen provides both fragmentation-based plasmid sequencing library preparation solutions for third-generation sequencing platforms.
Using the 13305ES fragmentation and ligation workflow, plasmids ranging from different sizes and input amounts (5–50 ng) were prepared for nanopore sequencing.
Figure 3. Fragment distribution of plasmid full-length sequencing on Nanopore (5 ng vs. 50 ng)
Related Products
|
Category |
Product Name |
Catalog Number |
|
Plasmid Synthesis(Enzymatic) |
14540ES |
|
|
14404ES |
||
|
17293ES |
||
|
14525ES |
||
|
14538ES |
||
|
10125ES |
||
|
Plasmid Extraction |
19037ES |
|
|
80510ES |
||
|
DNA Quantification |
12643ES |
|
|
High-Throughput 96-Well Nucleic Acid Quantification Fluorometer |
80575ES |
|
|
96-Channel Fluorescence Nucleic Acid Quantifier |
80576ES |
|
|
Homologous Recombination Cloning |
10923ES |
|
|
Residual Plasmid DNA Detection |
41323ES |
|
|
Plasmid Sequencing Library Preparation |
13305ES |
|
|
13304ES |
||
|
Hieff™ HC Fast Tagmentase (Customizable Embedded Sequences) |
12914ES |